T-cell cytokine pattern at three time points during specific immunotherapy for mite-sensitive asthma

Clinical and Experimental Allergy

Volumn 30, Issue 3, 2000, Pages 341-347

  Majori, M ^a,c   Caminati, A ^a   Corradi, M ^a   Brianti, E ^b   Scarpa, S ^b   Pesci, A ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Programma Dipendenze SerT   (Italy)

^c Ist Clin delle Malat Apparato R   (Italy)

Author keywords

Asthma; Cytokines; Flow cytometry; Immunotherapy; Peripheral blood; T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; IMMUNOTHERAPY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SCORING SYSTEM; T LYMPHOCYTE;

ADULT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MITES; TH1 CELLS; TH2 CELLS;

EID: 0034107253     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00701.x     Document Type: Article

References (33)

1. Noon L, Cantab BO. Prophylactic inoculation against hay fever. Lancet 1911; 1:1572-3.
2. Frankland AW, Augustin R. Prophylaxis of summer hay fever and asthma. Lancet 1954; 1:1055-7.
3. Golden DB, Meyers DA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Clinical relevance of the venom specific immunoglobulin G antibody level during immunotherapy. J Allergy Clin Immunol 1982; 69:489-93.
4. Yan-der-Zee JS, Aalberse RC. The role of IgG in immediate-type hypersensitivity. Eur Respir J Suppl 1991; 13:91S-6S.
5. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154:4187-94.
6. O'Brien RM, Byron KA, Varigos GA, Thomas WR. House dust mite immunotherapy results in a decrease in Der, p 2-specific IFN-γ and IL-4 expression by circulating T lymphocytes. Clin Exp Allergy 1997; 27:46-51.
7. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993; 178:2123-30.
8. Ebner C, Siemann U, Bohle B et al. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl, p 1, a major grass pollen allergen. Clin Exp Allergy 1997; 27:1007-15.
9. Van Bever HP, Vereecke IF, Bridts CH, De Clerck LS, Stevens WJ. Comparison between the in vitro cytokine production of mononuclear cells of young asthmatics with and without immunotherapy (IT). Clin Exp Allergy 1998; 28:943-9.
10. Pène J, Desroches A, Paradis L et al. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. J Allergy Clin Immunol 1998; 102:571-8.
11. Varney VA, Hamid QA, Gaga M et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993; 92:644-51.
12. Durham SR, Ying S, Varney VA et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J Allergy Clin Immunol 1996; 97:1356-65.
13. Lack G, Nelson HS, Amran D et al. Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-γ production in CD4+ T cells. J Allergy Clin Immunol 1997; 99:530-8.
14. Jung T, Schauer U, HeusSeries C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159:197-207.
15. Majori M, Corradi M, Caminati A, Cacciani G, Bertacco S, Pesci A. Predominant Th1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease. J Allergy Clin Immunol 1999; 103:458-62.
16. Imada M, Estelle F, Simons R, Jay FT, Hayglass KT. Allergen-stimulated interleukin-4 and interferon-γ production in primary culture: responses of subjects with allergic rhinitis and normal controls. Immunology 1995; 85:373-80.
17. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-44.
18. Picker LJ, Singh MK, Zdraveski Z et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995; 86:1408-19.
19. Petersen CM, Ilso Christensen EI, Andresen BS, Moller BK. Internalization, lysosomal degradation and new synthesis of surface membrane CD4 in phorbol ester-activated T-lymphocytes and U-937 cells. Exp Cell Res 1992; 201:160-73.
20. Schall TJ, O'Hehir RE, Goeddel DV, Lamb JR. Uncoupling of cytokine mRNA expression and protein secretion during the induction phase of T cell anergy. J Immunol 1992; 148:381-7.
21. Tang M, Kemp A. Production and secretion of interferon-gamma (IFN-γ) in children with atopic dermatitis. Clin Exp Immunol 1994; 95:66-72.
22. Sad S, Mosmann TR. Single IL-2-secreting precursor CD4 T-cell can develop into either Th1 or Th2 cytokine secreting phenotype. J Immunol 1994; 153:3514-22.
23. 2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996; 98:1676-83.
24. MacDonald SM, Naclerio RM, Hamilton RG, Langdon JM, White JM, Lichtenstein LM. Cytokine measurements in patients receiving standard immunotherapy. J Allergy Clin Immunol 1994; 93:230.
25. Saloga J, Renz H, Lack G et al. Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen. J Clin Invest 1993; 91:133-40.
26. Parish CR, Liew FY. Immune response to chemically modified flagellin 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J Exp Med 1972; 135:298-311.
27. DeKruyff RH, Fang Y, Umetsu DT. IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type. J Immunol 1992; 149:3468-76.
28. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102:98-106.
29. Majori M, Bertacco S, Piccoli ML, Meley R, Pileggi V, Pesci A. Specific immunotherapy downregulates peripheral blood CD4 and CD8 T-lymphocyte activation in grass pollen-sensitive asthma. Eur Respir J 1998; 11:1263-7.
30. Bonno M, Fujisawa T, Iguchi K et al. Mite-specific induction of interleukin-2 receptor on T lymphocytes from children with mite-sensitive asthma: modified immune response with immunotherapy. J Allergy Clin Immunol 1996; 97:680-8.
31. Malling HJ, Weeke B. Immunotherapy position paper. Allergy 1993; (Suppl. 48): 9-35.
32. Tipton WR, Nelson HS. Experience with daily immunotherapy in 59 adult allergic patients. J Allergy Clin Immunol 1982; 69:194-9.
33. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151:969-74.